Passage Bio, Inc. (PASG)
NASDAQ: PASG · Real-Time Price · USD
5.52
+0.49 (9.74%)
At close: May 13, 2026, 4:00 PM EDT
5.51
-0.01 (-0.18%)
After-hours: May 13, 2026, 7:36 PM EDT
Passage Bio Market Cap
Passage Bio has a market cap or net worth of $17.71 million as of May 13, 2026. Its market cap has decreased by -12.66% in one year.
Market Cap
17.71M
Enterprise Value
-9.81M
1-Year Change
-12.66%
Ranking
Category
Stock Price
$5.52
Market Cap Chart
Since February 28, 2020, Passage Bio's market cap has decreased from $956.75M to $17.71M, a decrease of -98.15%. That is a compound annual growth rate of -47.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2026 | 16.14M | -56.98% |
| Dec 31, 2025 | 37.51M | 7.08% |
| Dec 31, 2024 | 35.03M | -36.74% |
| Dec 29, 2023 | 55.37M | -26.45% |
| Dec 30, 2022 | 75.28M | -78.09% |
| Dec 31, 2021 | 343.58M | -70.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Feb 28, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Theriva Biologics | 15.65M |
| NewcelX | 15.27M |
| Lexaria Bioscience | 14.99M |
| Genenta Science | 14.86M |
| Vyome Holdings | 13.83M |
| BioLineRx | 13.50M |
| Cyclerion Therapeutics | 13.48M |
| Chemomab Therapeutics | 13.18M |